|
1
|
Czauderna P, Lopez-Terrada D, Hiyama E,
Häberle B, Malogolowkin MH and Meyers RL: Hepatoblastoma state of
the art: pathology, genetics, risk stratification, and
chemotherapy. Curr Opin Pediatr. 26:19–28. 2014. View Article : Google Scholar
|
|
2
|
Stocker JT: Hepatic tumors in children.
Clin Liver Dis. 5:259–281. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Green LK and Silva EG: Hepatoblastoma in
an adult with metastasis to the ovaries. Am J Clin Pathol.
92:110–115. 1989.PubMed/NCBI
|
|
4
|
Gupta SK, Oommen S, Aubry MC, Williams BP
and Vlahakis NE: Integrin α9β1 promotes malignant tumor growth and
metastasis by potentiating epithelial-mesenchymal transition.
Oncogene. 32:141–150. 2013. View Article : Google Scholar
|
|
5
|
Yadav A, Kumar B, Datta J, Teknos TN and
Kumar P: IL-6 promotes head and neck tumor metastasis by inducing
epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling
pathway. Mol Cancer Res. 9:1658–1667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meng F, Han Y, Staloch D, Francis T,
Stokes A and Francis H: The H4 histamine receptor agonist,
clobenpropit, suppresses human cholangiocarcinoma progression by
disruption of epithelial mesenchymal transition and tumor
metastasis. Hepatology. 54:1718–1728. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zucchini-Pascal N, Peyre L and Rahmani R:
Crosstalk between beta-catenin and snail in the induction of
epithelial to mesenchymal transition in hepatocarcinoma: role of
the ERK1/2 pathway. Int J Mol Sci. 14:20768–20792. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cannito S, Novo E, Compagnone A, et al:
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal
transition in cancer cells. Carcinogenesis. 29:2267–2278. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagamalleswari K and Safer D: Sequestered
actin in chick embryo fibroblasts. Mol Cell Biochem. 209:63–67.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reti R, Kwon E, Qiu P, Wheater M and Sosne
G: Thymosin beta4 is cytoprotective in human gingival fibroblasts.
Eur J Oral Sci. 116:424–430. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roy P, Rajfur Z, Jones D, Marriott G, Loew
L and Jacobson K: Local photorelease of caged thymosin beta4 in
locomoting keratocytes causes cell turning. J Cell Biol.
153:1035–1048. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mu H, Ohashi R, Yang H, et al: Thymosin
beta10 inhibits cell migration and capillary-like tube formation of
human coronary artery endothelial cells. Cell Motil Cytoskeleton.
63:222–230. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Francis Godschalk M: Pressure ulcers: a
role for thymosin beta4. Ann N Y Acad Sci. 1112:413–417. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Smart N, Rossdeutsch A and Riley PR:
Thymosin beta4 and angiogenesis: modes of action and therapeutic
potential. Angiogenesis. 10:229–241. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jo JO, Kang YJ, Ock MS, Kleinman HK, Chang
HK and Cha HJ: Thymosin β4 expression in human tissues and in
tumors using tissue microarrays. Appl Immunohistochem Mol Morphol.
19:160–167. 2011. View Article : Google Scholar
|
|
16
|
Wang WS CP, Hsiao HL, Ju SY and Su Y:
Overexpression of the thymosin beta-4 gene is associated with
malignant progression of SW480 colon cancer cells. Oncogene.
22:3297–3306. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bataille F, Rohrmeier C, Bates R, et al:
Evidence for a role of epithelial mesenchymal transition during
pathogenesis of fistulae in Crohn’s disease. Inflamm Bowel Dis.
14:1514–1527. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Flier SN, Tanjore H, Kokkotou EG, Sugimoto
H, Zeisberg M and Kalluri R: Identification of epithelial to
mesenchymal transition as a novel source of fibroblasts in
intestinal fibrosis. J Biol Chem. 285:20202–20212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim NS, Kang YJ, Jo JO, et al: Elevated
expression of thymosin β4, vascular endothelial growth factor
(VEGF), and hypoxia inducible factor (HIF)-1α in early-stage
cervical cancers. Pathol Oncol Res. 17:493–502. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu JM, Kusinski M, Ilic V, et al:
Overexpression of the angiogenic tetrapeptide AcSDKP in human
malignant tumors. Anticancer Res. 28:2813–2817. 2008.PubMed/NCBI
|
|
21
|
Cha HJ, Jeong MJ and Kleinman HK: Role of
thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer
Inst. 95:1674–1680. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim A, Son M, Kim KI, et al: Elevation of
intracellular cyclic AMP inhibits NF-kappaB-mediated thymosin beta4
expression in melanoma cells. Exp Cell Res. 315:3325–3335. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kielosto M, Nummela P, Järvinen K, Yin M
and Hölttä E: Identification of integrins alpha6 and beta7 as
c-Jun- and transformation-relevant genes in highly invasive
fibrosarcoma cells. Int J Cancer. 125:1065–1073. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kobayashi T, Okada F, Fujii N, et al:
Thymosin-beta4 regulates motility and metastasis of malignant mouse
fibrosarcoma cells. Am J Pathol. 160:869–882. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Radisky DC: Epithelial-mesenchymal
transition. J Cell Sci. 118:4325–4326. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Semb H and Christofori G: The
tumor-suppressor function of E-cadherin. Am J Hum Genet.
63:1588–1593. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang HC, Hu CH, Tang MC, Wang WS, Chen PM
and Su Y: Thymosin beta4 triggers an epithelial-mesenchymal
transition in colorectal carcinoma by upregulating integrin-linked
kinase. Oncogene. 26:2781–2790. 2007. View Article : Google Scholar
|
|
29
|
Katsuno Y, Lamouille S and Derynck R:
TGF-β signaling and epithelial-mesenchymal transition in cancer
progression. Curr Opin Oncol. 25:76–84. 2013. View Article : Google Scholar
|
|
30
|
Lauffenburger DA and Horwitz AF: Cell
migration: a physically integrated molecular process. Cell.
84:359–369. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pollard TD and Borisy GG: Cellular
motility driven by assembly and disassembly of actin filaments.
Cell. 112:453–465. 2003. View Article : Google Scholar : PubMed/NCBI
|
